Global

Pharmaceutical Sciences Experts

Dr. Stephen P. Holly

Associate Professor
Pharmaceutical Sciences
Campbell University
United States of America

Biography

Dr. Stephen P. Holly is currently an associate professor in the department of pharmaceutical sciences in Campbell University. He obtained his PhD from Washington University. He completed his BS in Clemson University. Previously he worked as an Adjunct professor in University of North Carolina at Chapel Hill. He is a Prinicipal Investigator, NIH Metabolomics Pilot and Feasibility Grant (1U24DK097193, Project No. 0213486, 2015 - 2016). Invited speaker, Cell Biology of Megakaryocytes & Platelets Gordon Research Conference, Barga (Lucca), Italy, February 26 – March 3, 2017. His research has progressed from a general interest in molecular signaling pathways that regulate important biological events such as cell adhesion to a more focused analysis of signaling pathways that regulate human platelet and megakaryocyte activation during normal blood clotting (hemostasis) or pathological aggregate formation (thrombosis). He is currently evaluating physiological role(s) of AADACL1 in rat models of thrombosis and hemostasis.Invited speaker, International Society for Thrombosis and Hemostasis 2015 Congress, Toronto, Canada, June 20-25, 2015. He published many editorials in various reputed journals.

Research Interest

Molecular signaling pathway, cell adhesion etc.

Publications

  • Leisner TM, Moran C, Holly SP, Parise LV. CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling. Oncogene. 2013 Aug 22;32(34):4017.

  • Holly SP, Chang JW, Li W, Niessen S, Phillips RM, Piatt R, Black JL, Smith MC, Boulaftali Y, Weyrich AS, Bergmeier W. Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation. Chemistry & biology. 2013 Sep 19;20(9):1125-34.

  • Holly SP, Chang JW, Li W, Niessen S, Phillips RM, Piatt R, Black JL, Smith MC, Boulaftali Y, Weyrich AS, Bergmeier W. Chemoproteomic discovery of AADACL1 as a regulator of human platelet activation. Chemistry & biology. 2013 Sep 19;20(9):1125-34.

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recent Expert Updates
  • Matthew L Stone
    Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.   Matthew
    Dr. Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone Matthew
    Dr. L Stone Matthew
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  L Stone
    Dr. L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr. Matthew L Stone
    Dr. Matthew L Stone
    pediatrics
    University of Virginia Health System; Charlottesville, VA
    United States of America
  • Dr.  R Sameh
    Dr. R Sameh
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   R Ismail,
    Dr. R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Sameh R Ismail,
    Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   Sameh R Ismail,
    Dr. Sameh R Ismail,
    pediatrics
    King Abdul Aziz University
    United Arab Emirates
  • Dr.   William
    Dr. William
    pediatrics
    Maimonides Medical Center
    United States of America